The Current Treatment of Pulmonary Arterial Hypertension

This publication has 40 references indexed in Scilit:

• Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
  The American Journal of Cardiology, 2005
• PDGF signaling in pulmonary arterial hypertension
  Journal of Clinical Investigation, 2005
• Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
  Circulation, 2005
• Survival with first-line bosentan in patients with primary pulmonary hypertension
  European Respiratory Journal, 2005
• Elevated Basic Fibroblast Growth Factor Levels in Patients With Pulmonary Arterial Hypertension
  Chest, 2004
• Prostacyclin Induces Apoptosis of Vascular Smooth Muscle Cells by a cAMP-Mediated Inhibition of Extracellular Signal-Regulated Kinase Activity and Can Counteract the Mitogenic Activity of Endothelin-1 or Basic Fibroblast Growth Factor
  Circulation Research, 2004
• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease
  Thorax, 1999
• Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.
  Journal of Clinical Investigation, 1998
• Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
  Circulation, 1982